vs
Side-by-side financial comparison of Incyte (INCY) and Western Union CO (WU). Click either name above to swap in a different company.
Incyte is the larger business by last-quarter revenue ($1.3B vs $982.7M, roughly 1.3× Western Union CO). Incyte runs the higher net margin — 23.8% vs 6.6%, a 17.3% gap on every dollar of revenue. On growth, Incyte posted the faster year-over-year revenue change (19.8% vs 0.0%). Over the past eight quarters, Incyte's revenue compounded faster (10.4% CAGR vs -1.9%).
Incyte Corporation is an American multinational pharmaceutical company with headquarters in Wilmington, Delaware. The company currently operates manufacturing and R&D locations in North America, Europe, and Asia.
The Western Union Company is an American multinational financial services corporation headquartered in Denver, Colorado.
INCY vs WU — Head-to-Head
Income Statement — Q1 FY2026 vs Q1 FY2026
| Metric | ||
|---|---|---|
| Revenue | $1.3B | $982.7M |
| Net Profit | $303.3M | $64.7M |
| Gross Margin | — | — |
| Operating Margin | 23.7% | 12.5% |
| Net Margin | 23.8% | 6.6% |
| Revenue YoY | 19.8% | 0.0% |
| Net Profit YoY | 91.7% | -47.6% |
| EPS (diluted) | $1.47 | $0.41 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $1.3B | $982.7M | ||
| Q4 25 | $1.5B | $972.0M | ||
| Q3 25 | $1.4B | $985.3M | ||
| Q2 25 | $1.2B | $983.6M | ||
| Q1 25 | $1.1B | $938.7M | ||
| Q4 24 | $1.2B | $1.0B | ||
| Q3 24 | $1.1B | $993.4M | ||
| Q2 24 | $1.0B | $1.0B |
| Q1 26 | $303.3M | $64.7M | ||
| Q4 25 | $299.3M | $114.4M | ||
| Q3 25 | $424.2M | $139.6M | ||
| Q2 25 | $405.0M | $122.1M | ||
| Q1 25 | $158.2M | $123.5M | ||
| Q4 24 | $201.2M | $385.7M | ||
| Q3 24 | $106.5M | $264.8M | ||
| Q2 24 | $-444.6M | $141.0M |
| Q1 26 | — | — | ||
| Q4 25 | 92.0% | 33.6% | ||
| Q3 25 | 92.8% | 34.7% | ||
| Q2 25 | 93.5% | 34.6% | ||
| Q1 25 | 93.0% | 34.0% | ||
| Q4 24 | 92.5% | 35.0% | ||
| Q3 24 | 92.4% | 34.2% | ||
| Q2 24 | 92.7% | 35.0% |
| Q1 26 | 23.7% | 12.5% | ||
| Q4 25 | 22.3% | 19.1% | ||
| Q3 25 | 32.5% | 20.5% | ||
| Q2 25 | 43.6% | 19.6% | ||
| Q1 25 | 19.5% | 18.9% | ||
| Q4 24 | 25.6% | 17.5% | ||
| Q3 24 | 12.8% | 16.6% | ||
| Q2 24 | -45.8% | 18.7% |
| Q1 26 | 23.8% | 6.6% | ||
| Q4 25 | 19.9% | 11.8% | ||
| Q3 25 | 31.1% | 14.2% | ||
| Q2 25 | 33.3% | 12.4% | ||
| Q1 25 | 15.0% | 13.2% | ||
| Q4 24 | 17.1% | 37.9% | ||
| Q3 24 | 9.4% | 26.7% | ||
| Q2 24 | -42.6% | 13.8% |
| Q1 26 | $1.47 | $0.41 | ||
| Q4 25 | $1.46 | $0.36 | ||
| Q3 25 | $2.11 | $0.43 | ||
| Q2 25 | $2.04 | $0.37 | ||
| Q1 25 | $0.80 | $0.36 | ||
| Q4 24 | $0.90 | $1.14 | ||
| Q3 24 | $0.54 | $0.78 | ||
| Q2 24 | $-2.04 | $0.41 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | ||
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $909.2M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $5.6B | $910.5M |
| Total Assets | $7.3B | $8.1B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $909.2M | ||
| Q4 25 | $3.1B | $1.2B | ||
| Q3 25 | $2.5B | $947.8M | ||
| Q2 25 | $2.0B | $1.0B | ||
| Q1 25 | $1.9B | $1.3B | ||
| Q4 24 | $1.7B | $1.5B | ||
| Q3 24 | $1.3B | $1.1B | ||
| Q2 24 | $987.3M | $1.0B |
| Q1 26 | — | — | ||
| Q4 25 | — | $2.9B | ||
| Q3 25 | — | $2.5B | ||
| Q2 25 | — | $2.5B | ||
| Q1 25 | — | $2.5B | ||
| Q4 24 | — | $3.0B | ||
| Q3 24 | — | $2.1B | ||
| Q2 24 | — | $2.1B |
| Q1 26 | $5.6B | $910.5M | ||
| Q4 25 | $5.2B | $957.8M | ||
| Q3 25 | $4.7B | $925.4M | ||
| Q2 25 | $4.2B | $883.6M | ||
| Q1 25 | $3.7B | $939.4M | ||
| Q4 24 | $3.4B | $968.9M | ||
| Q3 24 | $3.2B | $652.7M | ||
| Q2 24 | $3.0B | $440.8M |
| Q1 26 | $7.3B | $8.1B | ||
| Q4 25 | $7.0B | $8.3B | ||
| Q3 25 | $6.3B | $7.8B | ||
| Q2 25 | $5.8B | $8.0B | ||
| Q1 25 | $5.7B | $8.3B | ||
| Q4 24 | $5.4B | $8.4B | ||
| Q3 24 | $5.0B | $7.7B | ||
| Q2 24 | $4.7B | $8.0B |
| Q1 26 | — | — | ||
| Q4 25 | — | 3.01× | ||
| Q3 25 | — | 2.70× | ||
| Q2 25 | — | 2.83× | ||
| Q1 25 | — | 2.61× | ||
| Q4 24 | — | 3.04× | ||
| Q3 24 | — | 3.29× | ||
| Q2 24 | — | 4.88× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | ||
|---|---|---|
| Operating Cash FlowLast quarter | — | $109.0M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | 4.8% |
| Cash ConversionOCF / Net Profit | — | 1.68× |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $109.0M | ||
| Q4 25 | $543.3M | $135.4M | ||
| Q3 25 | $559.4M | $260.4M | ||
| Q2 25 | $44.7M | $-300.0K | ||
| Q1 25 | $266.1M | $148.2M | ||
| Q4 24 | $381.2M | $134.0M | ||
| Q3 24 | $310.9M | $212.1M | ||
| Q2 24 | $-575.6M | $-33.8M |
| Q1 26 | — | — | ||
| Q4 25 | — | $115.5M | ||
| Q3 25 | — | $252.7M | ||
| Q2 25 | — | $-7.8M | ||
| Q1 25 | — | $144.8M | ||
| Q4 24 | — | $119.7M | ||
| Q3 24 | — | $205.1M | ||
| Q2 24 | — | $-38.9M |
| Q1 26 | — | — | ||
| Q4 25 | — | 11.9% | ||
| Q3 25 | — | 25.6% | ||
| Q2 25 | — | -0.8% | ||
| Q1 25 | — | 15.4% | ||
| Q4 24 | — | 11.8% | ||
| Q3 24 | — | 20.6% | ||
| Q2 24 | — | -3.8% |
| Q1 26 | — | 4.8% | ||
| Q4 25 | — | 2.0% | ||
| Q3 25 | — | 0.8% | ||
| Q2 25 | — | 0.8% | ||
| Q1 25 | — | 0.4% | ||
| Q4 24 | — | 1.4% | ||
| Q3 24 | — | 0.7% | ||
| Q2 24 | — | 0.5% |
| Q1 26 | — | 1.68× | ||
| Q4 25 | 1.82× | 1.18× | ||
| Q3 25 | 1.32× | 1.87× | ||
| Q2 25 | 0.11× | -0.00× | ||
| Q1 25 | 1.68× | 1.20× | ||
| Q4 24 | 1.89× | 0.35× | ||
| Q3 24 | 2.92× | 0.80× | ||
| Q2 24 | — | -0.24× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.